# Modular Medical CEO James E. Besser Adds 10,000 Shares, Raising Direct Stake to 24,067

> Modular Medical CEO James E. Besser bought 10,000 common shares at $2.0256 each, lifting his direct holdings to 24,067 shares in the Pivot pump maker.

- Published: 2026-11-20T03:26:27+00:00
- Section: Business
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-20/modular-medical-ceo-besser-share-purchase
- Source: [The future of trading](https://capital.com/en-int/news/modular-medical-ceo-james-e-besser-reports-acquisition-of-20-256)

## Key takeaways

- Modular Medical CEO James E. Besser purchased 10,000 common shares at $2.0256 each, a total of $20,256.
- Besser's direct holdings rose to 24,067 common shares after the purchase.
- The transaction was disclosed via EDGAR on November 19, 2026.

Modular Medical Chief Executive James E. Besser bought 10,000 common shares at $2.0256 each, a purchase worth $20,256, lifting his direct holdings to 24,067 common shares. [The future of trading](https://capital.com/en-int/news/modular-medical-ceo-james-e-besser-reports-acquisition-of-20-256) reported the acquisition, which was disclosed via EDGAR on November 19, 2026.

## Besser's Purchase and His Stake

Besser's purchase covers 10,000 common shares of [Modular Medical](https://akta.pro/company-profiles/000026o/modular-medical) at $2.0256 per share. The filing puts the total value of the transaction at $20,256. After the purchase, Besser's direct holdings stood at 24,067 common shares.

The company published the original disclosure via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission, on November 19, 2026. The filing carries the reference ID 0000919574-26-008202.

Modular Medical is a San Diego-based medical device company, founded in 2015, that develops tubeless insulin patch pumps, including the FDA-cleared Pivot system, for U.S. adults with diabetes on multiple daily injections who have not adopted pump therapy. The company sells hardware and disposables through endocrinology practices and a direct-to-patient site.

## Pivot's Path to Market

According to akta.pro [company records](https://akta.pro/company-data), Modular Medical received FDA 510(k) clearance for the Pivot tubeless insulin patch pump in April 2026, enabling commercial sales in the United States. In June 2026 the company launched commercial availability of Pivot in the U.S. market with first shipments to high-volume endocrinology practices, moving from development-stage to commercial-stage.

The same records show Modular Medical implemented a 1-for-30 reverse stock split effective March 31, 2026, to raise its stock price to meet Nasdaq's minimum bid price requirement of $1.00, reducing outstanding shares from approximately 139.8 million to 4.66 million. The records list total funding of $65.5 million, with the last round dated April 20, 2026.

## Earlier Steps Toward Commercialization

In September 2026, Modular Medical announced a contract with a national U.S. pharmacy benefit manager making the Pivot tubeless patch pump available through that PBM, which the company described as a significant commercialization milestone to broaden patient access, [Stock Titan](https://akta.pro/news-signals) reported. Commercialization began in five markets in October 2026, according to Benzinga.

Modular Medical launched two digital education resources in October 2026 to help prospective users familiarize themselves with the Pivot insulin delivery system before formal training, Stock Titan reported. CEO Jeb Besser presented at the Webull Emerging & Innovative Companies Webinar on October 14, 2026, where the company's Pivot tubeless patch pump was described as a wearable insulin delivery platform for continuous subcutaneous infusion over three days.

## What Comes Next for Pivot

Modular Medical has said its Pivot tubeless patch pump launch covers five strategically selected U.S. markets beginning October 2026, and commercialization began in those five markets that month.

## Companies in this story

- [Modular Medical company profile](https://akta.pro/company-profiles/000026o/modular-medical) · website: https://www.modular-medical.com

---
News for Agent · https://newsforagent.com/llms.txt
